JOSEPH C. PAPA - 13 May 2025 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)

Role: President and CEO, Director
Signature: /s/ Jessica Perl, Attorney-in-fact
Issuer symbol: EBS
Transactions as of: 13 May 2025
Transactions value $: $349,800
Form type: 4
Filing time: 15 May 2025, 16:02:40 UTC
Previous filing: 12 Mar 2025
Next filing: 12 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
PAPA JOSEPH C	President and CEO, Director	300 PROFESSIONAL DRIVE, GAITHERSBURG	/s/ Jessica Perl, Attorney-in-fact	15 May 2025	0001242215

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EBS	Common Stock	Purchase	$350K	+60K	+21.24%	$5.83	343K	13 May 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On May 13, 2025, Mr. Papa purchased an aggregate of 60,000 shares of Emergent BioSolutions Inc. common stock. For reporting purposes, purchase prices within a $1 range have been aggregated and the weighted average purchase price has been reported. The price ranges were: $5.76 - $5.88. The Company maintains a record of the transactions and copies will be provided upon request.